Although mutations in PIK3CA are also a common feature in colorectal cancer, the relationship between PIK3CA and CRC outcome is not as well established as those involving KRAS or BRAF. Nevertheless, PIK3CA mutations are associated with worse prognosis when accompanied by KRAS mutations [44]. The gene discussed is KRAS; the disease is colorectal carcinoma.